{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:37Z","timestamp":1793138497828,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jad.2025.120606","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:13:20Z","timestamp":1763183600000},"page":"120606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Glucose biomarkers and antidepressant response: A scoping review of interventions targeting major depressive disorder and metabolic dysfunction"],"prefix":"10.1016","volume":"395","author":[{"given":"Dara","family":"Silver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vasileiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie S.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Goubran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Swardfager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Lipsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120606_bb5005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/NDT.S5421","article-title":"Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)","author":"Abrahamian","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.120606_bb5010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/NDT.S33679","article-title":"Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)","volume":"8","author":"Abrahamian","year":"2012","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2020.11747","article-title":"Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial","volume":"324","author":"Ali","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13098-023-01149-z","article-title":"Antidepressants and type 2 diabetes: highways to knowns and unknowns","volume":"15","author":"Alruwaili","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/metabo13030384","article-title":"Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance","volume":"13","author":"Al-Sayyar","year":"2023","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000100369","article-title":"Safety and Efficacy of s-Citalopram in Patients with Co-Morbid Major Depression and Diabetes Mellitus","volume":"54","author":"Amsterdam","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2025.120606_bb5025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpsychires.2018.10.021","article-title":"Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: findings from the METADAP cohort","volume":"107","author":"Asmar","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.120606_bb0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","article-title":"Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression","volume":"98","author":"Bekhbat","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The Bidirectional Relationship of Depression and Inflammation: Double Trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1370\/afm.1344","article-title":"Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial","volume":"10","author":"Bogner","year":"2012","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.jad.2025.120606_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2022.12.066","article-title":"Achievement of glycemic control and antidepressant medication use in comorbid depression and type 2 diabetes","volume":"324","author":"Brieler","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12888-015-0543-5","article-title":"Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial","volume":"15","author":"Brouwer","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2013.04.008","article-title":"The change of insulin levels after six weeks antidepressant use in drug-na\u00efve major depressive patients","volume":"150","author":"Chang","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12740\/APP\/103602","article-title":"Two birds with one stone: How depression and distress in diabetes respond to antidepressants","volume":"21","author":"Chauhan","year":"2019","journal-title":"Arch. Psychiatry Psychother."},{"key":"10.1016\/j.jad.2025.120606_bb0060","first-page":"280","article-title":"Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?","volume":"11","author":"Christensen","year":"2020","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.genhosppsych.2013.04.014","article-title":"Early experience of a pilot intervention for patients with depression and chronic medical illness in an urban ACO","volume":"35","author":"Chung","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/dc18-2400","article-title":"Program ACTIVE II: Outcomes From a Randomized, Multistate Community-Based Depression Treatment for Rural and Urban Adults With Type 2 Diabetes","volume":"42","author":"De Groot","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb5015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41398-025-03544-8","article-title":"A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder","volume":"15","author":"Decker","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YCO.0b013e32835a4206","article-title":"Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults","volume":"26","author":"Deuschle","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.120606_bb0090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/1357633X17730419","article-title":"Effect of psychotherapy for depression via home telehealth on glycemic control in adults with type 2 diabetes: Subgroup analysis of a randomized clinical trial","volume":"24","author":"Egede","year":"2018","journal-title":"J. Telemed. Telecare"},{"issue":"14","key":"10.1016\/j.jad.2025.120606_bb5020","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1017\/S0033291722003919","article-title":"Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort","volume":"53","author":"El Asmar","year":"2023","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.jad.2025.120606_bb0095","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/ejn.15992","article-title":"Pro-inflammatory cytokines IL-1\u03b1, IL-6 and TNF-\u03b1 in major depressive disorder: Sex-specific associations with psychological symptoms","volume":"57","author":"Elgellaie","year":"2023","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb5030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psym.2011.12.009","article-title":"Depressive symptom deterioration among predominantly hispanic diabetes patients in safety net care","volume":"53","author":"Ell","year":"2012","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e3181ac9b0b","article-title":"Metabolic Assessment of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Pooled Analysis of 2 Studies","volume":"29","author":"Fava","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120606_bb0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genhosppsych.2016.01.002","article-title":"Psychiatric referral and glycemic control of Egyptian type 2 diabetes mellitus patients with depression","volume":"40","author":"Fawzi","year":"2016","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120606_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104758","article-title":"Insulin resistance in depression: A large meta-analysis of metabolic parameters and variation","volume":"139","author":"Fernandes","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0115","first-page":"231","article-title":"Depression treatment and its impact upon the quality of life in patients with diabetes type 2 - the Croatian study","volume":"22","author":"Filipci\u0107","year":"2010","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/dc09-1238","article-title":"Diabetes Distress but Not Clinical Depression or Depressive Symptoms Is Associated With Glycemic Control in Both Cross-Sectional and Longitudinal Analyses","volume":"33","author":"Fisher","year":"2010","journal-title":"Diabetes Care"},{"issue":"sup3","key":"10.1016\/j.jad.2025.120606_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1185\/03007995.2011.619176","article-title":"The impact of blood glucose monitoring on depression and distress in insulin-na\u00efve patients with type 2 diabetes","volume":"27","author":"Fisher","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jpsychires.2007.06.003","article-title":"Metabolism in adipose tissue in response to citalopram and trimipramine treatment \u2013 An in situ microdialysis study","volume":"42","author":"Flechtner-Mors","year":"2008","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/a0022850","article-title":"Glycemic control among Latinos with type 2 diabetes: The role of social-environmental support resources","volume":"30","author":"Fortmann","year":"2011","journal-title":"Health Psychol."},{"key":"10.1016\/j.jad.2025.120606_bb0140","series-title":"Insulin Resistance","author":"Freeman","year":"2024"},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0145","first-page":"239","article-title":"Metabolism Matters in Mental Health","volume":"10","author":"Freyberg","year":"2025","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajp.2013.03.007","article-title":"Diabetes with comorbid depression: Role of SSRI in better glycemic control","volume":"6","author":"Gehlawat","year":"2013","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PSY.0b013e318042588d","article-title":"Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus","volume":"69","author":"Georgiades","year":"2007","journal-title":"Psychosom. Med."},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.jcp.0000132441.27854.0d","article-title":"Comparing the Effects of 8-Week Treatment With Fluoxetine and Imipramine on Fasting Blood Glucose of Patients With Major Depressive Disorder","volume":"24","author":"Ghaeli","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2025.120606_bb0165","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jpepsy\/jsz064","article-title":"Indirect Effects of a Cognitive-Behavioral Intervention on Adolescent Weight and Insulin Resistance Through Decreasing Depression in a Randomized Controlled Trial","volume":"44","author":"Gulley","year":"2019","journal-title":"J. Pediatr. Psychol."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2004.12.018","article-title":"Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients","volume":"36","author":"G\u00fclseren","year":"2005","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12874-020-0897-3","article-title":"Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation","volume":"20","author":"Harrison","year":"2020","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jad.2025.120606_bb0185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/NDT.S85711","article-title":"Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a&nbsp;double-blind, randomized, clinical trial","author":"He","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s11136-015-1165-6","article-title":"Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial","volume":"25","author":"Huang","year":"2016","journal-title":"Qual. Life Res."},{"issue":"10159","key":"10.1016\/j.jad.2025.120606_bb0195","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.13217","article-title":"Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus","volume":"1391","author":"Joseph","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb5045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s43440-024-00690-6","article-title":"Efficacy of probiotic adjuvant therapy in women with major depressive disorder: insights from a case series study","volume":"77","author":"J\u00fanior","year":"2025","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb5050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdiacomp.2015.10.017","article-title":"The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS)","volume":"30","author":"Kammer","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.jad.2025.120606_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.jad.2025.120606_bb0210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.61.10.1042","article-title":"The Pathways Study: A Randomized Trial of Collaborative Care in Patients With Diabetesand Depression","volume":"61","author":"Katon","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/09513590500216800","article-title":"Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age","volume":"21","author":"Kauffman","year":"2005","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0220","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2025.120606_bb0225","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2337\/dc10-1187","article-title":"Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes","volume":"33","author":"Kivim\u00e4ki","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0230","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s43440-024-00621-5","article-title":"Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder","volume":"76","author":"Krupa","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"18","key":"10.1016\/j.jad.2025.120606_bb5060","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00213-016-4361-3","article-title":"Association between major depression and cardiovascular risk: the role of antidepressant medication","volume":"233","author":"Kuehl","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.120606_bb0235","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.22688","article-title":"The Association of Hemoglobin A1c Levels and Depression Among Adults With Diabetes in the United States","author":"Langberg","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.25","article-title":"Is increased antidepressant exposure a contributory factor to the obesity pandemic?","volume":"6","author":"Lee","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.120606_bb5065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psychres.2018.06.061","article-title":"Factors related to metabolic parameters in medicated patients with major depressive disorder\u2013\u2013a naturalistic study","volume":"268","author":"Lee","year":"2018","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb5070","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/jcm14051664","article-title":"Potential impact of choline alphoscerate on depressive symptoms in association with insulin resistance in elderly patients with type 2 diabetes","volume":"14","author":"Lee","year":"2025","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0245","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.psychres.2015.10.013","article-title":"Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response","volume":"230","author":"Lin","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120606_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119503","article-title":"Predicting rTMS treatment response in depression: use of machine learning models to identify the roles of metabolic and clinical factors","volume":"388","author":"Liu","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120606_bb5130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/210406","volume":"2015","author":"Lovren\u010di\u0107","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb5075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00006842-199705000-00007","article-title":"Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial","volume":"59","author":"Lustman","year":"1997","journal-title":"Psychosom. Med."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0163-8343(98)00039-5","article-title":"Predicting response to cognitive behavior therapy of depression in type 2 diabetes","volume":"20","author":"Lustman","year":"1998","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/dc06-1769","article-title":"Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion","volume":"30","author":"Lustman","year":"2007","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jad.2025.120606_bb5080","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2105\/AJPH.2013.301394","article-title":"Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular disease","volume":"103","author":"Ma","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0265","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/ijms20040874","article-title":"Insulin Resistance and Oxidative Stress in the Brain: What\u2019s New?","volume":"20","author":"Maciejczyk","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-022-02475-8","article-title":"Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients","volume":"129","author":"Maier","year":"2022","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb5085","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s40001-025-02871-2","article-title":"Association of antidiabetic medications with psychiatric disorders in patients with type 2 diabetes: a cross-sectional study","volume":"30","author":"Mansour","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","article-title":"Major depressive disorder","volume":"9","author":"Marx","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jad.2025.120606_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111191","article-title":"Glucose metabolism impairment in major depressive disorder","volume":"221","author":"Meng","year":"2025","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0285","first-page":"74","article-title":"Clinical Significance of Serum IL-6 and TNF-\u03b1 Levels in Patients with Metabolic Syndrome","volume":"6","author":"Mohammadi","year":"2017","journal-title":"Rep Biochem Mol Biol."},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0290","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/PSY.0000000000000348","volume":"78","author":"Moncrieft","year":"2016","journal-title":"Psychosom. Med."},{"issue":"6","key":"10.1016\/j.jad.2025.120606_bb0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000095341.32154.8f","article-title":"African Women With Depression: The Effect of Imipramine and Fluoxetine on Body Mass Index and Leptin Secretion","volume":"23","author":"Moosa","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0305","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pcd.2015.06.003","article-title":"Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study","volume":"10","author":"Moulton","year":"2016","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.jad.2025.120606_bb0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpsychires.2014.01.006","article-title":"Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes","volume":"52","author":"Musselman","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.120606_bb0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin Resistance and Alzheimer\u2019s Disease: Bioenergetic Linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0320","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.7274","article-title":"Web-Based Cognitive Behavior Therapy for Depression in People With Diabetes Mellitus: A Randomized Controlled Trial","volume":"19","author":"Newby","year":"2017","journal-title":"J. Med. Internet Res."},{"issue":"10","key":"10.1016\/j.jad.2025.120606_bb5090","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/meta.2000.9515","article-title":"Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis","volume":"49","author":"Okamura","year":"2000","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5152\/npa.2016.12373","article-title":"Metabolic Effects of Antidepressant Treatment","volume":"54","author":"Olguner Eker","year":"2017","journal-title":"Noro Psikiyatr. Ars."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0330","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/dc11-2055","article-title":"Bidirectional Association Between Depression and Metabolic Syndrome","volume":"35","author":"Pan","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0340","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/dc09-1940","article-title":"Depression and Insulin Resistance","volume":"33","author":"Pearson","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0345","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s12671-018-0908-1","article-title":"Effects of Mindfulness on Psychological Distress and HbA1c in People with Diabetes","volume":"9","author":"Pearson","year":"2018","journal-title":"Mindfulness"},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0350","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MLR.0b013e318215d0c9","article-title":"A Randomized Trial of Telephonic Counseling Plus Walking for Depressed Diabetes Patients","volume":"49","author":"Piette","year":"2011","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb5100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pnpbp.2007.07.028","article-title":"Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity","volume":"32","author":"Pinar","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb5095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/26350106251361363","article-title":"Lack of association of emotional distress with insulin initiation in the GRADE randomized diabetes comparative effectiveness trial","volume":"51","author":"Presley","year":"2025","journal-title":"Sci. Diabetes Self-Manag. Care"},{"key":"10.1016\/j.jad.2025.120606_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.728810","article-title":"Update on the Relationship Between Depression and Neuroendocrine Metabolism","volume":"15","author":"Qiu","year":"2021","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/02698811221132473","article-title":"Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder","volume":"37","author":"Rashidian","year":"2023","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.jad.2025.120606_bb0365","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eurpsy.2018.09.009","article-title":"Early life adversity blunts responses to pioglitazone in depressed, overweight adults","volume":"55","author":"Robakis","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.120606_bb5105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.genhosppsych.2016.05.006","article-title":"Impact of a national collaborative care initiative for patients with depression and diabetes or cardiovascular disease","volume":"44","author":"Rossom","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120606_bb0370","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: A systematic review","volume":"142","author":"Roy","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb5110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40337-022-00571-4","article-title":"Disordered eating behaviour in adolescents with type 1 diabetes on continuous subcutaneous insulin infusion; relation to body image, depression and glycemic control","volume":"10","author":"Salah","year":"2022","journal-title":"J. Eat. Disord."},{"issue":"11","key":"10.1016\/j.jad.2025.120606_bb0375","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/07399332.2020.1821689","article-title":"Recreational training improves cardiovascular adaptations, metabolic profile and mental health of elderly women with type-2 diabetes mellitus","volume":"42","author":"Sanches","year":"2021","journal-title":"Health Care Women Int."},{"issue":"11","key":"10.1016\/j.jad.2025.120606_bb0380","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jdiacomp.2017.08.004","article-title":"Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study","volume":"31","author":"Schmitt","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb5115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.beth.2015.10.005","article-title":"Feasibility of pairing behavioral activation with exercise for women with type 2 diabetes and depression: the get it study pilot randomized controlled trial","volume":"47","author":"Schneider","year":"2016","journal-title":"Behav. Ther."},{"issue":"18","key":"10.1016\/j.jad.2025.120606_bb0385","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.3390\/ijms22189987","article-title":"Insulin and Insulin Resistance in Alzheimer\u2019s Disease","volume":"22","author":"S\u0119dzikowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jad.2025.120606_bb0390","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12160-016-9801-0","article-title":"A Randomized Controlled Trial to Prevent Depression and Ameliorate Insulin Resistance in Adolescent Girls at Risk for Type 2 Diabetes","volume":"50","author":"Shomaker","year":"2016","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.jad.2025.120606_bb5120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2023.05.007","article-title":"Effect of modernized collaborative care for depression on depressive symptoms and cardiovascular disease risk biomarkers: eIMPACT randomized controlled trial","volume":"112","author":"Stewart","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.120606_bb0395","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2147\/NDT.S414782","article-title":"Advancements in Transcranial Magnetic Stimulation Research and the Path to Precision","volume":"19","author":"Sun","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0400","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jad.2025.120606_bb0405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/0145482X0309700404","article-title":"Effects of a Psychoeducational Group on Mood and Glycemic Control in Adults with Diabetes and Visual Impairments","volume":"97","author":"Trozzolino","year":"2003","journal-title":"J Vis Impair Blind."},{"key":"10.1016\/j.jad.2025.120606_bb0410","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"issue":"01","key":"10.1016\/j.jad.2025.120606_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1463423617000512","article-title":"Glucose and cholesterol stabilization in patients with type 2 diabetes mellitus with depressive and anxiety symptoms by problem-solving therapy in primary care centers in Mexico City","volume":"19","author":"Villamil-Salcedo","year":"2018","journal-title":"Prim. Health Care Res. Dev."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2006.11.009","article-title":"Hypercortisolemic depression is associated with the metabolic syndrome in late-life","volume":"32","author":"Vogelzangs","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2025.120606_bb5125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbi.2024.10.033","article-title":"Running therapy or antidepressants as treatments for immunometabolic depression in patients with depressive and anxiety disorders: a secondary analysis of the MOTAR study","volume":"123","author":"Vreijling","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.120606_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106050","article-title":"Depression, antidepressants and low hemoglobin level in the Paris Prospective Study III: A cross-sectional analysis","volume":"135","author":"Vulser","year":"2020","journal-title":"Prev. Med."},{"key":"10.1016\/j.jad.2025.120606_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106427","article-title":"A randomized trial to decrease risk for diabetes among Cambodian Americans with depression: Intervention development, baseline characteristics and process outcomes","volume":"106","author":"Wagner","year":"2021","journal-title":"Contemp. Clin. Trials"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12966-023-01509-y","article-title":"Secondary analysis of a randomized trial testing community health educator interventions for diabetes prevention among refugees with depression: effects on nutrition, physical activity and sleep","volume":"20","author":"Wagner","year":"2023","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"issue":"2","key":"10.1016\/j.jad.2025.120606_bb0440","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12160-014-9606-y","article-title":"Who Benefits from Diabetes Self-Management Interventions? The Influence of Depression in the Latinos en Control Trial","volume":"48","author":"Wang","year":"2014","journal-title":"Ann. Behav. Med."},{"issue":"12","key":"10.1016\/j.jad.2025.120606_bb0445","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4088\/JCP.v67n1204","article-title":"Improved Insulin Sensitivity in 80 Nondiabetic Patients With MDD After Clinical Remission in a Double-Blind, Randomized Trial of Amitriptyline and Paroxetine","volume":"67","author":"Weber-Hamann","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120606_bb0450","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1192\/bjp.161.1.94","article-title":"The Effects of Electroconvulsive Therapy on Plasma Insulin and Glucose in Depression","volume":"161","author":"Williams","year":"1992","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2025.120606_bb0455","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/1570159X14666151208113006","article-title":"Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression","volume":"14","author":"Won","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2025.120606_bb0460","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jad.2016.06.018","article-title":"Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study)","volume":"203","author":"Woo","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2025.120606_bb0465","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10865-011-9359-z","article-title":"Improvement in glycemic control following a diabetes education intervention is associated with change in diabetes distress but not change in depressive symptoms","volume":"35","author":"Zagarins","year":"2012","journal-title":"J. Behav. Med."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725020488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725020488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:44:36Z","timestamp":1765424676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725020488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":113,"alternative-id":["S0165032725020488"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120606","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose biomarkers and antidepressant response: A scoping review of interventions targeting major depressive disorder and metabolic dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120606"}}